Illumina Inc. (ILMN)

308.79
NASDAQ : Health Technology
Prev Close 319.21
Day Low/High 308.40 / 319.27
52 Wk Low/High 225.81 / 372.61
Avg Volume 1.00M
Exchange NASDAQ
Shares Outstanding 147.00M
Market Cap 46.92B
EPS 5.60
P/E Ratio 57.41
Div & Yield N.A. (N.A)

Latest News

The New #40 Most Shorted Nasdaq 100 Component: Illumina

The New #40 Most Shorted Nasdaq 100 Component: Illumina

The most recent short interest data has been released for the 02/15/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

5 Attractive Ways to Invest in Oncology

5 Attractive Ways to Invest in Oncology

Experts offer their top stock ideas in oncology detection and treatment.

Hot Cancer Detection Stock Still Has Room to Run

Hot Cancer Detection Stock Still Has Room to Run

Guardant's liquid biopsy lets oncologists see all of the genomic information of a patient's tumor with a simple blood test. The alternative is a tissue biopsy which can be expensive and risky.

Illumina Could Rally to Break Its Downtrend

Illumina Could Rally to Break Its Downtrend

Here's how we would play ILMN stock right now.

Yeti Holdings, Cronos Group, Manitowoc: 'Mad Money' Lightning Round

Yeti Holdings, Cronos Group, Manitowoc: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Yeti Holdings, Cronos Group, Manitowoc, Crispr Therapeutics, Palo Alto Networks, Etsy and more.

China Deal or No Deal?: Cramer's 'Mad Money' Recap (Monday 2/11/19)

China Deal or No Deal?: Cramer's 'Mad Money' Recap (Monday 2/11/19)

Cramer's got the winners, the losers and the wild cards in the China trade brouhaha.

Health Care Is About to Improve Dramatically; Here's How to Play it

Health Care Is About to Improve Dramatically; Here's How to Play it

Governments and physicians around the globe struggle to deliver high quality healthcare at a reasonable price. But fresh medical technology innovators are coming, and there's one in particular worth looking at.

Sue Siegel (Photo: Business Wire)

Sue Siegel (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) announced today that Sue Siegel has joined the company's Board of Directors effective February 5, 2019.

Illumina Sinks on Fourth-Quarter Earnings Miss

Illumina Sinks on Fourth-Quarter Earnings Miss

Shares of Illumina fall after the genetic testing tools company misses Wall Street's fourth-quarter earnings expectations.

Illumina Reports Financial Results For Fourth Quarter And Fiscal Year 2018

Illumina Reports Financial Results For Fourth Quarter And Fiscal Year 2018

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2018.

Illumina To Announce Fourth Quarter And Fiscal Year 2018 Financial Results On Tuesday, January 29, 2019

Illumina To Announce Fourth Quarter And Fiscal Year 2018 Financial Results On Tuesday, January 29, 2019

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2018 following the close of market on Tuesday, January 29, 2019.

Illumina Becomes #44 Most Shorted Nasdaq 100 Component, Replacing American Airlines Group

Illumina Becomes #44 Most Shorted Nasdaq 100 Component, Replacing American Airlines Group

The most recent short interest data has been released for the 12/14/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Illumina Moves Up In Market Cap Rank, Passing Raytheon

Illumina Moves Up In Market Cap Rank, Passing Raytheon

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Illumina Inc has taken over the #115 spot from Raytheon Co. , according to The Online Investor.

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.

Illumina Moves Up In Analyst Rankings, Passing FedEx

Illumina Moves Up In Analyst Rankings, Passing FedEx

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Illumina Inc has taken over the #81 spot from FedEx Corp , according to ETF Channel. Below is a chart of Illumina Inc versus FedEx Corp plotting their respective rank within the S&P 500 over time (ILMN plotted in blue; FDX plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.

Gene Editing Offers Promise of Personalized Health Care -- Here's How to Play It

Gene Editing Offers Promise of Personalized Health Care -- Here's How to Play It

CRISPR is a gene-editing technique that uses molecular scissors to precisely snip genetic code. With it, researchers have modified genes to help blind people see, cure sickle cell disease in some patients and speed up the development of numerous new drug treatments.

Illumina Announces A New Genotyping Array And Scientific Contribution To Three Genome Centers To Support The All Of Us Research Program

Illumina Announces A New Genotyping Array And Scientific Contribution To Three Genome Centers To Support The All Of Us Research Program

Illumina, Inc. (NASDAQ: ILMN) today announced the launch of its new high-density genotyping array, the Infinium™ Global Diversity Array.

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast.

Illumina To Acquire Pacific Biosciences For Approximately $1.2 Billion, Broadening Access To Long-Read Sequencing And Accelerating Scientific Discovery

Illumina To Acquire Pacific Biosciences For Approximately $1.2 Billion, Broadening Access To Long-Read Sequencing And Accelerating Scientific Discovery

Illumina, Inc. (NASDAQ: ILMN) and Pacific Biosciences (NASDAQ:PACB) today announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.

Helix Launches The New DNA Discovery Kit

Helix Launches The New DNA Discovery Kit

Just in time for the holidays, Helix starts shipping the new DNA Discovery Kit which offers introductory insights, a DNA test kit and a $20 promotional gift card for only $49.99.

Illumina Launches TruSight Oncology 500 To Power Comprehensive, Accurate, Pan-Cancer Tumor Profiling

Illumina Launches TruSight Oncology 500 To Power Comprehensive, Accurate, Pan-Cancer Tumor Profiling

Illumina, Inc. (NASDAQ: ILMN) today announces the launch of TruSight TM Oncology 500 (TSO 500), a comprehensive pan-cancer assay designed to identify known and emerging tumor biomarkers.

Illumina Reports Financial Results For Third Quarter Of Fiscal Year 2018

Illumina Reports Financial Results For Third Quarter Of Fiscal Year 2018

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the third quarter of fiscal year 2018.

Illumina Becomes #33 Most Shorted Nasdaq 100 Component, Replacing Comcast

Illumina Becomes #33 Most Shorted Nasdaq 100 Component, Replacing Comcast

The most recent short interest data has been released for the 09/28/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Illumina To Announce Third Quarter 2018 Financial Results On Tuesday, October 23, 2018

Illumina To Announce Third Quarter 2018 Financial Results On Tuesday, October 23, 2018

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for third quarter 2018 following the close of market on Tuesday, October 23, 2018.

Jim Cramer: Know Which Way the Wind Blows Before You Pick Stocks

Jim Cramer: Know Which Way the Wind Blows Before You Pick Stocks

PepsiCo, GE and just like the weather, the stock market is subject to change.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Illumina Becomes #38 Most Shorted Nasdaq 100 Component, Replacing Cadence Design Systems

Illumina Becomes #38 Most Shorted Nasdaq 100 Component, Replacing Cadence Design Systems

The most recent short interest data has been released for the 09/14/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Jim Cramer: Valuations Now Have No Relation to Common Sense

Jim Cramer: Valuations Now Have No Relation to Common Sense

Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.

TheStreet Quant Rating: B (Buy)